ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

TGF-β1 peptide-based inhibitor P144 ameliorates renal fibrosis after ischemia-reperfusion injury by modulating alternatively activated macrophages

Li, Delun; Zhang, Jian; Yuan, Siyu; Wang, Chao; Chang, Jiakai; Tong, Yan; Liu, Ran; Sang, Tian; Li, Lili; Li, Jijun; Ouyang, Qing*; Chen, Xiangmei*广东药学院; 国家纳米科学中心; 中国科学院; 1
Cell Proliferation2022-10DOI: 10.1111/cpr.13299
6被引5阅读
引用收藏
分享

摘要

Objectives Ischemia-reperfusion injury (IRI) is a major cause of chronic renal fibrosis. Currently, numerous therapies have shown a minimal effect on the blockade of fibrosis progression. Here, the therapeutic potential of peptide-based TGF-beta 1 inhibitor P144 in IRI-induced renal fibrosis and the underlying mechanism were analyzed. Materials and Methods The unilateral ischemia-reperfusion injury with the contralateral nephrectomy model was established, and the P144 was administered intravenously 1d/14d after the onset of IRI. The histopathology and immunofluorescence staining were used to detect renal fibrosis and macrophage infiltration. The in vivo fluorescence imaging was used to measure the bio-distribution of P144. The transwell assays were used to observe the migration of macrophages. RT-qPCR and western blot were used to analyze TGF-beta 1 signaling. Results P144 ameliorated the accumulation of extracellular matrix in the kidney and improved the renal function in the unilateral ischemia-reperfusion injury plus contralateral nephrectomy model. Mechanistically, P144 downregulated the TGF-beta 1-Smad3 signaling at both the transcriptional and translational levels and further reduced the TGF-beta 1-dependent infiltration of macrophages to the injured kidney. Additionally, P144 blocked the polarization of macrophages to an M2-like phenotype induced by TGF-beta 1 in vitro, but showed no effect on their proliferation. Conclusions Our study showed that the TGF-beta 1 peptide-based inhibitor P144 decreased renal fibrosis through the blockade of the TGF-beta 1-Smad3 signaling pathway and the modulation of macrophage polarization, suggesting its potential therapeutic use in IRI-induced renal fibrosis.

学科与关键词

关键词
GROWTH-FACTOR-BETASYNTHETIC PEPTIDETGF-BETAKIDNEYDIFFERENTIATION
相关
加载中…
  • NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury
    Xie, Zhi-yong; Dong, Wei; Zhang, Li; Wang, Meng-jie; Xiao, Zhen-meng; Zhang, Yu-hua; Shi, Wan-xin; Huang, Ying; Yang, Yan; Li, Cui-li; Fu, Lei; Zhao, Xing-chen; Li, Rui-zhao; Li, Zhi-lian; Chen, Yuan-han; Ye, Zhi-ming; Liu, Shuang-xin; Dong, Zheng; Liang, Xin-ling*Acta Pharmacologica Sinica, 2022, 43(8): 2081-2093.被引 7
  • FoxM1 inhibition ameliorates renal interstitial fibrosis by decreasing extracellular matrix and epithelial-mesenchymal transition
    Wang, Yanhui; Zhou, Qiaoling*; Tang, Rong; Huang, Yuyu; He, TingJournal of Pharmacological Sciences, 2020, 143(4): 281-289.被引 13
  • IRF-4 deficiency reduces inflammation and kidney fibrosis after folic acid-induced acute kidney injury
    Chen, Meixin; Wen, Xianjie; Gao, Ying; Liu, Benquan; Zhong, Chaoqun; Nie, Jiayi; Liang, Hua*International Immunopharmacology, 2021, 100: 108142.被引 12
查看全部 →

发表信息

论文状态
公开发表
期刊
Cell Proliferation
发表日期
2022-10
卷期
第 55 卷, 第 10 期
页码
e13299
DOI
10.1111/cpr.13299
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82000657, 82030025]

作者

  • L

    Li, Delun (第一作者)

    guangdong pharmaceut univ · 1 · chinese peoples liberat army gen hosp

  • Z

    Zhang, Jian

    1 · chinese peoples liberat army gen hosp

查看全部 12 位作者收起作者
  • Y

    Yuan, Siyu

    1 · chinese peoples liberat army gen hosp

  • W

    Wang, Chao

    1 · chinese peoples liberat army gen hosp · guangdong pharmaceut univ

  • C

    Chang, Jiakai

    1 · chinese peoples liberat army gen hosp

  • T

    Tong, Yan

    1 · chinese peoples liberat army gen hosp

  • L

    Liu, Ran

    1 · chinese peoples liberat army gen hosp

  • S

    Sang, Tian

    1 · chinese peoples liberat army gen hosp

  • L

    Li, Lili

    cas · natl ctr nanosci & technol ncnst

  • L

    Li, Jijun

    1 · chinese peoples liberat army gen hosp

  • O

    Ouyang, Qing (通讯)

    1 · chinese peoples liberat army gen hosp

  • C

    Chen, Xiangmei (通讯)

    guangdong pharmaceut univ · 1 · chinese peoples liberat army gen hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417